Sun Pharma stops eye-care drug production at Indian plant amid quality issues

The cessation of manufacturing activities follows a Sun Pharma recall and reports that regulators found fault with the company’s quality system.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top